The Board of Directors of iNtRON Biotechnology, Inc. has authorized a buyback plan on June 19, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,200 KRW | -1.12% |
|
+0.16% | -29.38% |
Jun. 19 | INtRON Biotechnology, Inc. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
Jun. 19 | INtRON Biotechnology, Inc. authorizes a Buyback Plan. | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.38% | 150M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- INtRON Biotechnology, Inc. authorizes a Buyback Plan.